Innovation Spotlight

Dr. Eric A. Rose Leads Advances in Clinical Devices

Mount Sinai Heart builds on its reputation as a leader of innovation with a solid corps of outstanding medical professionals whose technological advances have revolutionized the way medicine is practiced.

Eric A. Rose, MD, Chairman of the Department of Health Policy and Associate Director for Clinical Outcomes at Mount Sinai Heart, is a world-renowned, award-winning surgeon and scientist whose pioneering research has shaped patient care with its emphasis on clinical devices. Dr. Rose set a medical milestone in 1984 when he performed the world's first successful pediatric heart transplant.

The National Institutes of Health (NIH) has continually supported Dr. Rose’s research. Dr. Rose has participated in NIH grants totaling more than $25 million. Dr. Rose holds three patents, including one for fibrin surgical glue.

Dr. Rose led the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) — the first trial to conclusively demonstrate that long-term use of mechanical circulatory support devices prolongs and enhances life in end-stage heart disease patients who are unable to undergo heart transplantation.

Dr. Rose has authored and co-authored more than 300 peer-reviewed publications on such topics as cardiovascular surgery, ventricular assist devices, and cardiac transplantation. He has written two books: Management of End-Stage Heart Disease, and Second Opinion: The Columbia Presbyterian Guide to Surgery.